Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Although the conventional prevalence of myotonic dystrophy is 1:8,000, the prevalence in Korean population was recently reported as 1:1,245. With higher domestic result than expected, we aimed to investigate the clinical characteristics of pregnancies complicated by congenital myotonic dystrophy in our institution. Methods: We have reviewed 11 paired cases of neonates diagnosed with congenital myotonic dystrophy and their mothers between July 2004 and May 2014, with clinical features including maternal history of infertility, prenatal ultrasonographic findings, and neonatal outcomes. Cytosine-thymine-guanine (CTG) repeat expansion in the myotonic dystrophy protein kinase gene of both neonates and their mothers was also examined. Results: None of mother was aware of their myotonic dystrophy traits before pregnancy. History of infertility followed by assisted reproductive technology accounted for 57.1% (4/7). Distinctive prenatal ultrasonographic finding was severe idiopathic polyhydramnios (66.7%, 4/6) with median amniotic fluid index of 43 (range, 37 to 66). In 37.5% (3/8) cases, decreased fetal movement was evident during prenatal ultrasound examination. For neonatal outcomes, more than half (6/11) were complicated with preterm birth and the proportion of 1-minute Apgar score <4 and 5-minute Apgar score <7 was 44.4% (4/9) and 66.7% (6/9), respectively. Most of neonates were admitted to the neonatal intensive care unit (9/10) because of hypotonia with respiratory problems and there was one infant death. Median number of cytosine-thymine-guanine repeats in mothers and neonates was 400 (range, 166 to 1,000) and 1,300 (range, 700 to 2,000), respectively. Conclusion: Our data suggest that severe idiopathic polyhydramnios with decreased fetal movement in pregnant women, especially with a history of infertility, requires differential diagnosis of congenital myotonic dystrophy.
Abstract
Objective: Although the conventional prevalence of myotonic dystrophy is 1:8,000, the prevalence in Korean population was recently reported as 1:1,245. With higher domestic result than expected, we aimed to investigate the clinical characteristics of pregnancies complicated by congenital myotonic dystrophy in our institution. Methods: We have reviewed 11 paired cases of neonates diagnosed with congenital myotonic dystrophy and their mothers between July 2004 and May 2014, with clinical features including maternal history of infertility, prenatal ultrasonographic findings, and neonatal outcomes. Cytosine-thymine-guanine (CTG) repeat expansion in the myotonic dystrophy protein kinase gene of both neonates and their mothers was also examined. Results: None of mother was aware of their myotonic dystrophy traits before pregnancy. History of infertility followed by assisted reproductive technology accounted for 57.1% (4/7). Distinctive prenatal ultrasonographic finding was severe idiopathic polyhydramnios (66.7%, 4/6) with median amniotic fluid index of 43 (range, 37 to 66). In 37.5% (3/8) cases, decreased fetal movement was evident during prenatal ultrasound examination. For neonatal outcomes, more than half (6/11) were complicated with preterm birth and the proportion of 1-minute Apgar score <4 and 5-minute Apgar score <7 was 44.4% (4/9) and 66.7% (6/9), respectively. Most of neonates were admitted to the neonatal intensive care unit (9/10) because of hypotonia with respiratory problems and there was one infant death. Median number of cytosine-thymine-guanine repeats in mothers and neonates was 400 (range, 166 to 1,000) and 1,300 (range, 700 to 2,000), respectively. Conclusion: Our data suggest that severe idiopathic polyhydramnios with decreased fetal movement in pregnant women, especially with a history of infertility, requires differential diagnosis of congenital myotonic dystrophy.
참고문헌 (23)
- Barnes PR, "Clinical and genetic aspects of myotonic dystrophy", Br J Hosp Med, 50, pp.22~30 (1993)
- Mahadevan M, "Myotonic dystrophy mutation:an unstable CTG repeat in the 3’ untranslated region of the gene", Science, 255, pp.1253~1255 (1992)
- Lopez de Munain A, "Anticipation in myotonic dystrophy: a parental-sex-related phenomenon", Neuroepidemiology, 13, pp.75~78 (1994)
- Logigian EL, "Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1", Neurology, 62, pp.1081~1089 (2004)
- Udd B, "The myotonic dystrophies: molecular, clinical, and therapeutic challenges", Lancet Neurol, 11, pp.891~905 (2012)
- Meola G, "Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies", Acta Myol, 32, pp.154~165 (2013)
- Harper PS, "Congenital myotonic dystrophy in Britain. I. Clinical aspects", Arch Dis Child, 50, pp.505~513 (1975)
- Davies J, "Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations", J Med Genet, 29, pp.766~769 (1992)
- Harper PS, "Myotonic dystrophy" (2001), WB Saunders
- Jang JH, "Frequency of DMPK mutation carriers in Korean women of childbearing age", Clin Genet, 86, pp.398~399 (2014)
- Prior TW, "Technical standards and guidelines for myotonic dystrophy type 1testing", Genet Med, 11, pp.552~555 (2009)
- Kamsteeg EJ, "Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2", Eur J Hum Genet, 20, pp.1203~1208 (2012)
- Zaki M, "Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome", Ultrasound Obstet Gynecol, 29, pp.284~288 (2007)
- Rudnik-Schoneborn S, "Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature", Eur J Obstet Gynecol Reprod Biol, 114, pp.44~53 (2004)
- Leonard RJ, "Swallowing in myotonic muscular dystrophy: a videofluoroscopic study", Arch Phys Med Rehabil, 82, pp.979~985 (2001)
- Theadom A, "Prevalence of muscular dystrophies:a systematic literature review", Neuroepidemiology, 43, pp.259~268 (2014)
- Harper PS, "The metabolic and molecular basis of inherited disease", pp.4227~4253 (1995), McGraw-Hill
- Srebnik N, "Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy", Reprod Biomed Online, 29, pp.94~101 (2014)
- Verpoest W, "The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract", J Assist Reprod Genet, 27, pp.327~333 (2010)
- Sholl JS, "Myotonic muscular dystrophy associated with ritodrine tocolysis", Am J Obstet Gynecol, 151, pp.83~86 (1985)
- Nasu K, "Rhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy", Gynecol Obstet Invest, 61, pp.53~55 (2006)
- Catanzarite V, "Respiratory compromise after MgSO4 therapy for preterm labor in a woman with myotonic dystrophy: a case report", J Reprod Med, 53, pp.220~222 (2008)
- Sparks SE, "Neonatal hypotonia", Clin Perinatol, 42, pp.363~371 (2015)